Jan 14, 2026 10:39AM
Jan 14, 2026 10:15AM
Jan 14, 2026 09:00AM
Jan 12, 2026 10:14AM
Jan 8, 2026 12:08PM
Jan 7, 2026 12:15PM
Dec 16, 2025 12:18PM Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
Dec 15, 2025 10:54AM
Dec 12, 2025 10:47AM
Dec 12, 2025 10:31AM
Dec 3, 2025 03:31PM
Dec 3, 2025 12:51PM
Nov 19, 2025 09:45AM
Aug 8, 2025 09:05AM Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep
Jul 10, 2025 06:50AM
Jun 30, 2025 07:01AM
Jun 30, 2025 07:00AM
Jun 11, 2025 08:30AM
Jun 11, 2025 07:00AM
May 14, 2025 04:01PM
Mar 7, 2025 07:00AM Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024
Jan 22, 2025 08:30AM
Nov 12, 2024 07:00AM
Aug 1, 2024 04:01PM
Jun 24, 2024 07:01AM
Jun 24, 2024 07:00AM
May 9, 2024 04:01PM
Mar 7, 2024 04:01PM Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Jan 9, 2024 10:25AM
Nov 3, 2023 07:00AM
Aug 14, 2023 07:00AM
May 5, 2023 07:00AM
Mar 3, 2023 07:00AM
Nov 7, 2022 08:03AM
Sep 7, 2022 07:00AM Oncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors
Aug 11, 2022 07:00AM
Jun 17, 2022 07:00AM
May 5, 2022 04:01PM
Mar 3, 2022 04:01PM
Nov 5, 2021 07:00AM
Aug 6, 2021 07:00AM
May 7, 2021 07:00AM Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results
Mar 5, 2021 07:30AM
Oct 17, 2019 07:04AM
Oct 17, 2019 07:00AM
Nov 12, 2018 07:00AM
Nov 12, 2018 07:00AM
Aug 3, 2018 07:00AM
Aug 3, 2018 07:00AM Oncolytics Biotech® Reports 2018 Second Quarter Results
Nov 5, 2015 06:30AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All